Ainos Inc WT AIMDW

$0.05 +0.00 (3.13%)

Valuation

Market cap
—
Revenue TTM
$120,000
Net income TTM
$-13,770,000
P/E (trailing)
—
P/E (forward)
—
Profit margin
—
Debt to equity
—

Trading

Volume
500
Avg volume
4,854
Day's range
$0.05 – $0.05
Shares out
—
Stochastic %K
54%
Beta
—
Analysts
—
Price target
—

Price

Company profile

Ainos, Inc., a dual-platform company, focusing artificial intelligence–based smelltech technologies and immune therapeutics. It offers AI Nose, an AI-based electronic olfaction system, which uses a smell language model to digitize scent into Smell IDs and turning into machine-readable data. The company provides its platforms for semiconductor manufacturing, robotics, and smart manufacturing industries; as well as sen...

Show more

Ainos, Inc., a dual-platform company, focusing artificial intelligence–based smelltech technologies and immune therapeutics. It offers AI Nose, an AI-based electronic olfaction system, which uses a smell language model to digitize scent into Smell IDs and turning into machine-readable data. The company provides its platforms for semiconductor manufacturing, robotics, and smart manufacturing industries; as well as senior care and women's health sectors. In addition, it develops VELDONA, a low-dose oral interferon platform for human and animal health applications, targeting rare, autoimmune, and infectious diseases. The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. Ainos, Inc. was incorporated in 1984 and is based in Houston, Texas. Ainos, Inc. is a subsidiary of Taiwan Carbon Nano Technology Corporation.

Phone
281 898 6586
Website
https://www.ainos.com
Address
3050 Post Oak Boulevard, Suite 510-T80, Houston, United States

Latest news

No headlines yet.